GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon - The Wall Street Journal

The pharmaceutical giant’s spinoff of Haleon is a bet that a greater focus on innovative drugs and vaccines will help accelerate growth.

GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-a… [+328 chars]

full article...